Compass Therapeutics, Inc. (CMPX)

Accolade Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.05	43.48	24.23	34.95	144.51	47.08
Short-Term Investments	71.59	83.24	128.23	151.66	-	-
Cash & Short-Term Investments	112.64	126.72	152.46	186.61	144.51	47.08
Cash Growth	-27.92%	-16.88%	-18.30%	29.13%	206.98%	86.05%
Prepaid Expenses	11.51	6.03	1.42	8.18	2.59	3.13
Total Current Assets	124.15	132.75	153.88	194.79	147.11	50.2
Property, Plant & Equipment	6.74	7.08	2.67	4.53	6.33	1.13
Other Long-Term Assets	0.57	0.57	0.32	0.32	0.32	0.58
Total Assets	131.45	140.4	156.88	199.65	153.76	51.91
Accounts Payable	1.58	2.25	4.09	3.38	0.87	1.06
Accrued Expenses	13.21	6.29	2.51	11.69	8.78	1.57
Current Portion of Long-Term Debt	-	-	-	-	-	7.47
Current Portion of Leases	0.11	0.34	1.2	1.1	0.99	-
Total Current Liabilities	14.9	8.87	7.8	16.17	10.63	10.1
Long-Term Debt	-	-	-	-	-	1.87
Long-Term Leases	6.27	6.3	0.54	1.84	3.05	-
Total Liabilities	21.17	15.17	8.34	18.01	13.68	11.97
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	491.39	489.69	463.8	454.74	373.66	191.35
Retained Earnings	-381.32	-364.68	-315.31	-272.81	-233.59	-151.41
Comprehensive Income & Other	0.19	0.21	0.04	-0.3	-	-
Total Common Equity	110.28	125.23	148.54	181.64	140.08	39.95
Shareholders' Equity	110.28	125.23	148.54	181.64	140.08	39.95
Total Liabilities & Equity	131.45	140.4	156.88	199.65	153.76	51.91
Total Debt	6.38	6.63	1.73	2.94	4.04	9.33
Net Cash (Debt)	106.25	120.09	150.73	183.67	140.48	37.74
Net Cash Growth	-31.38%	-20.33%	-17.94%	30.75%	272.20%	279.70%
Net Cash Per Share	0.77	0.87	1.19	1.75	2.23	1.23
Filing Date Shares Outstanding	138.28	138.28	137.59	126.31	100.83	51.22
Total Common Shares Outstanding	138.28	137.82	127.67	126.3	100.83	51.22
Working Capital	109.25	123.88	146.08	178.62	136.47	40.1
Book Value Per Share	0.80	0.91	1.16	1.44	1.39	0.78
Tangible Book Value	110.28	125.23	148.54	181.64	140.08	39.95
Tangible Book Value Per Share	0.80	0.91	1.16	1.44	1.39	0.78
Machinery	4.76	4.74	5.19	5.16	5.37	5.99
Leasehold Improvements	1.61	1.61	1.61	1.61	1.53	0.9

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q